top of page

Can this device be sold in Europe?

HealthChain provides Commercial Due Diligence for venture funds, accelerators and other investors in MedTech: an independent check, before the investment decision, of whether a startup's device can be sold in Europe, through whom and how fast.

healthchain-route-investors.png

Commercial Due Diligence

Technical and regulatory due diligence checks whether a device works and can be CE-marked. Commercial Due Diligence checks whether it can be sold: in which markets, through which channels, at what price and how fast.

What it covers
The reimbursement and procurement route in the key European markets, realistic channel options, red flags in the founders' commercial plan, and a realistic view of the first 24 months of sales.

​

How we work
We test the assumptions with distributors and hospital buyers we know. The scope, timing and a fixed fee are agreed with the fund for each deal.

​

Confidentiality
We sign an NDA before any deal materials are shared. If HealthChain later works with a startup we assessed for you, we tell you in advance.

bottom of page